Equine thrombospondin II and secreted protein acidic and cysteine-rich in a model of normal and pathological wound repair

Physiological Genomics

Volumn 38, Issue 2, 2009, Pages 149-157

  Miragliotta, Vincenzo ^b   Raphaël, Kevin ^a   Ipiña, Zoë ^a   Lussier, Jacques G ^a   Theoret, Christine L ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Angiogenesis; Horse model; SPARC; THBS2; Wound repair

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; OSTEONECTIN; THROMBOSPONDIN 2;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGY; CLONING; COMPARATIVE STUDY; CONTROLLED STUDY; DNA LIBRARY; GENE EXPRESSION; GRANULATION TISSUE; HORSE; HUMAN; IMMUNOHISTOCHEMISTRY; LIMB INJURY; MODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; SCREENING; SKIN; UPREGULATION; WOUND HEALING;

ANIMALS; CELL ADHESION MOLECULES; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; HORSES; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEONECTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOSPONDINS; WOUND HEALING;

EQUIDAE;

EID: 67650242154     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.90383.2008     Document Type: Article

References (47)

1. Agah A, Kyriakides TR, Letrondo N, Björkblom B, Bornstein P. Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis. Matrix Biol 22: 539-547, 2004.
2. Bagavandoss P, Sage EH, Vernon RB. Secreted protein, acidic and rich in cysteine (SPARC) and thrombospondin in the developing follicle and corpus luteum of the rat. J Histochem Cytochem 46: 1043-1049, 1998.
3. Bédard J, Brûlé S, Price CA, Silversides DW, Lussier JG. Serine protease inhibitor-E2 (SERPINE2) is differentially expressed in granulosa cells of dominant follicle in cattle. Mol Reprod Dev 64: 152-165, 2003.
4. Bornstein P, Armstrong LC, Hankenson KD, Kyriakides TR, Yang Z. Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol 19: 557-568, 2000.
5. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 7: 248-254, 1976.
6. Bradshaw AD, Sage HE. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107: 1049-1054, 2001.
7. Bradshaw AD, Reed MJ, Sage EH. SPARC-null mice exhibit accelerated cutaneous wound closure. J Histochem Cytochem 50: 1-10, 2002.
8. Braun S, Hanselmann C, Gassmann MG, auf dem Keller U, Born-Berclaz C, Chan K, Kan YW, Werner S. Nrf2, transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol Cell Biol 22: 5492-5505, 2002.
9. Brûlé S, Faure R, Dore M, Silversides DW, Lussier JG. Immunolocalization of vacuolar system-associated protein-60 (VASAP-60). Histochem Cell Biol 119: 371-381, 2003.
10. Carlson CB, Bernstein DA, Annis DS, Misenheimer TM, Hannah BL, Mosher DF, Keck JL. Structure of the calcium-rich signature domain of human thrombospondin-2. Nat Struct Mol Biol 12: 910-914, 2005.
11. Chandrasekaran V, Ambati J, Ambati BK, Taylor EW. Molecular docking and analysis of interactions between vascular endothelial growth factor (VEGF) and SPARC protein. J Mol Graph Model 26: 775-782, 2007.
12. Chlenski A, Liu S, Guerrero LJ, Yang Q, Tian Y, Salwen HR, Zage P, Cohn PL. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix. Int J Cancer 118: 310-316, 2006.
13. Emanuelsson O, Brunak S, von Heijne G, Nielsen H. Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2: 953-971, 2007.
14. Esposito I, Kayed H, Keleg S, Giese T, Sage EH, Schirmacher P, Friess H, Kleeff J. Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer. Neoplasia 9: 8-17, 2007.
15. Funk SE, Sage EH. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. J Cell Physiol 154: 53-63, 1993.
16. Greenbaum D, Colangelo C, Williams K, Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4: 117-124, 2003.
17. Hasselaar P, Sage EH. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 49: 272-283, 1992.
18. Hunzelmann N, Hafner M, Anders S, Krieg T, Nischt R. BM-40 (osteonectin, SPARC) is expressed both in the epidermal and in the dermal compartment of adult human skin. J Invest Dermatol 110: 122-126, 1998.
19. Jacobs KA, Leach DH, Fretz PB, Townsend HGG. Comparative aspects of the healing of excisional wounds on the leg and body of horses. Vet Surgery 13: 83-90, 1984.
20. Knottenbelt DC. Equine wound management: are there significant differences in healing at different sites on the body? Vet Dermatol 8: 273-290, 1997.
21. Kupprion C, Motamed K, Sage EH. SPARC (BM-40, Osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273: 29635-29640, 1998.
22. Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, and increased vascular density, and a bleeding diathesis. J Cell Biol 140: 419-430, 1998.
23. Kyriakides TR, Tam JW, Bornstein P. Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene. J Invest Dermatol 113: 782-787, 1999.
24. Kyriakides TR, Bornstein P. Matricellular proteins as modulators of wound healing and the foreign body response. Thromb Haemost 90: 986-992, 2003.
25. Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 8: 163-173, 1994.
26. Lange-Asschenfeldt B, Weninger W, Velasco P, Kyriakides TR, von Andrian UH, Bornstein P, Detmar M. Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice. Blood 99: 538-545, 2002.
27. Lefebvre-Lavoie J, Lussier JG, Theoret CL. Profiling of differentially expressed genes in wound margin biopsies of horses, using suppression subtractive hybridization. Physiol Genomics 22: 157-170, 2005.
28. Lepault E, Céleste C, Doré M, Martineau D, Theoret CL. Comparative study on microvascular occlusion and apoptosis in body and limb wounds in the horse. Wound Repair Regen 13: 520-529, 2005.
29. Lévesque V, Fayad T, Ndiaye K, Nahe Diouf M, Lussier JG. Sizeselection of cDNA libraries for the cloning of cDNAs after suppression subtractive hybridization. Biotechniques 35: 72-78, 2003.
30. Maclauchlan S, Skokos EA, Agah A, Zeng J, Tian W, Davidson JM, Bornstein P, Kyriakides TR. Enhanced angiogenesis and reduced contraction in thrombospondin 2-null wounds is associated with increased levels of matrix metalloproteinases 2 and 9 and soluble VEGF. J Histochem Cytochem 57: 301-313, 2009.
31. Miragliotta V, Ipina Z, Lefebvre-Lavoie J, Lussier JG, Theoret CL. Equine CTNNB1 and PECAM1 nucleotide structure and expression analyses in an experimental model of normal and pathological wound repair. BMC Physiol 8: 1-12, 2008.
32. Ndiaye K, Fayad T, Silversides DW, Sirois J, Lussier JG. Identification of downregulated messenger RNAs in bovine granulosa cells of dominant follicles following stimulation with human chorionic gonadotropin. Biol Reprod 73: 324-333, 2005.
33. Perkins NR, Reid SW, Morris RS. Profiling the New Zealand Thorough-bred racing industry. 2. Conditions interfering with training and racing. NZ Vet J 53: 69-76, 2005.
34. Puolakkainen P, Bradshaw AD, Kyriakides TR, Reed M, Brekken R, Wight T, Bornstein P, Ratner B, Sage EH. Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials. Am J Pathol 162: 627-635, 2003.
35. Reed MJ, Puolakkainen P, Lane TF, Dickerson D, Bornstein P, Sage EH. Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem 41: 1467-1477, 1993.
36. Schwartz AJ, Wilson DA, Keegan KG, Ganjam VK, Sun Y, Weber KT, Zhang J. Factors regulating collagen synthesis and degradation during second-intention healing of wounds in the thoracic region and the distal aspect of the forelimb of horses. Am J Vet Res 63: 1564-1570, 2002.
37. Si Z, Bhardwaj R, Rosch R, Mertens PR, Klosterhalfen B, Klinge U. Impaired balance of type I and type III procollagen mRNA in cultured fibroblasts of patients with incisional hernia. Surgery 131: 324-331, 2002.
38. Streit M, Velasco P, Riccardi L, Spencer L, Brown LF, Janes L, Lange-Asschenfeldt B, Yano K, Hawighorst T, Iruela-Arispe L, Detmar M. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J 19: 3272-3282, 2000.
39. Theoret CL, Barber SM, Moyana TN, Gordon JR. Expression of transforming growth factor 1, 3, and basic fibroblast growth factor in full-thickness skin wounds of equine limbs and thorax. Vet Surgery 30: 269-277, 2001.
40. Tremble PM, Lane TF, Sage EH, Werb Z. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol 121: 1433-1444, 1993.
41. Van den Boom R, Wilmink JM, O'Kane S, Wood J, Ferguson MWJ. Transforming growth factor-beta levels during second- intention healing are related to the different course of wound contraction in horses and ponies. Wound Repair Regen 10: 188-194, 2002.
42. Volpert OV, Zaichuk T, Zhou W, Reiher F, Ferguson TA, Stuart PM, Amin M, Bouck NP. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 8: 349-357, 2002.
43. Wilmink JM, van Weeren PR, Stolk PWT, Barneveld A. Differences in second-intention wound healing between horses and ponies: histological aspects. Equine Vet J 31: 61-67, 1999.
44. Wilmink JM, Veenman JN, van den Boom R, Rutten VP, Niewold TA, Broekhuisen-Davies JM, Lees R, Armstrong S, van Weeren PR, Barneveld A. Differences in polymorphonucleocyte function and local inflammatory response between horses and ponies. Equine Vet J 35: 561-569, 2003.
45. Yan J, Zeng Y, Jiang J, Zhou J, Yin Z, Wang Z, Zhu P. The expression patterns of vascular endothelial growth factor and thrombospondin 2 after corneal alkali burn. Colloids Surfaces B: Biointerfaces 60: 105-109, 2007.
46. Yang Z, Kyriakides TR, Bornstein P. Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol Biol Cell 11: 3353-3364, 2008.
47. Yunker CK, Golembieski W, Lemke N, Schultz CR, Cazacu S, Brodie C, Rempel SA. SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion. Int J Cancer 122: 2735-2743, 2008.